Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Transplant Patient Registry of Liver, Kidney and/or Pancreas

This study is currently recruiting participants. (see Contacts and Locations)
Verified July 2016 by Virginia Commonwealth University
Sponsor:
Information provided by (Responsible Party):
Virginia Commonwealth University
ClinicalTrials.gov Identifier:
NCT00238693
First received: October 11, 2005
Last updated: July 20, 2016
Last verified: July 2016
  Purpose
This is a registry of data collected from patient records, both of those who have a condition which may require transplantation and those who have undergone transplantation of the liver, kidney and/or pancreas.

Condition
End Stage Renal Disease
End Stage Liver Disease

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Transplant Registry: Patients Who May Require Transplantation and Those Who Have Undergone Transplantation of Liver, Kidney and/or Pancreas

Resource links provided by NLM:


Further study details as provided by Virginia Commonwealth University:

Primary Outcome Measures:
  • Data collection and maintenance [ Time Frame: Ongoing ] [ Designated as safety issue: No ]
    MAINTAIN A CURRENT, ACCURATE DATA BASE OF TRANSPLANT RECIPIENTS WITH REGARDS TO TRANSPLANT DATA AND OUTCOMES.


Estimated Enrollment: 15000
Study Start Date: April 2003
Estimated Study Completion Date: January 2025
Estimated Primary Completion Date: January 2025 (Final data collection date for primary outcome measure)
Detailed Description:
Honest Broker arrangement.
  Eligibility

Ages Eligible for Study:   Child, Adult, Senior
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
Patients followed in the transplant clinic at Virginia Commonwealth University Health System
Criteria

Inclusion Criteria:

  • Patients followed in the transplant clinic at Virginia Commonwealth University Health System
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00238693

Contacts
Contact: Adrian H Cotterell, MD, FACS 804-828-8911
Contact: Mary W Baldecchi, RN, BSN, CCRC 804-828-7925 mary.baldecchi@vcuhealth.org

Locations
United States, Virginia
Virginia Commonwealth University Health System Recruiting
Richmond, Virginia, United States, 23298
Contact: Adrian H Cotterell, MD, FACS    804-828-8911      
Sponsors and Collaborators
Virginia Commonwealth University
Investigators
Principal Investigator: Adrian H Cotterell, MD, FACS Virginia Commonwealth University Health System
  More Information

Responsible Party: Virginia Commonwealth University
ClinicalTrials.gov Identifier: NCT00238693     History of Changes
Other Study ID Numbers: VCU3127 
Study First Received: October 11, 2005
Last Updated: July 20, 2016
Health Authority: United States: Institutional Review Board

Keywords provided by Virginia Commonwealth University:
transplant
transplantation of liver, kidney, pancreas

Additional relevant MeSH terms:
Liver Diseases
Kidney Failure, Chronic
End Stage Liver Disease
Digestive System Diseases
Renal Insufficiency, Chronic
Renal Insufficiency
Kidney Diseases
Urologic Diseases
Liver Failure
Hepatic Insufficiency
Pancrelipase
Pancreatin
Gastrointestinal Agents

ClinicalTrials.gov processed this record on December 07, 2016